Intralipid in treatment of tramadol poioiiong
Phase 3
- Conditions
- Acute tramadol poisoning.Poisoning by narcotics and psychodysleptics [hallucinogens]
- Registration Number
- IRCT2017050120951N3
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion: history of tramadol poisoning, presence of pertinent clinical signs and symptoms, consent for participation in the study
Exclusion: co-ingestion, history of hypersensitivity to the drug, presence of a major internal disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Convulsion. Timepoint: at the time of admission and during hospital stay. Method of measurement: observation by nurse or physician.;Duration of hospitalization. Timepoint: at the time of discharge. Method of measurement: according to the hospital records.
- Secondary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: during hospital admission. Method of measurement: sphygnomanimeter.;Diastolic blood pressure. Timepoint: during hospital admission. Method of measurement: sphygnomanimeter.;Heart rate. Timepoint: during hospital admission. Method of measurement: by nurse or phycician.;Serum CPK level. Timepoint: at he time of admission and 24 hours later. Method of measurement: by lab.